Status:
COMPLETED
System for High-Intensity Evaluation During Radiotherapy
Lead Sponsor:
Duke University
Conditions:
Radiation Therapy Complication
Chemotherapeutic Toxicity
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This quality improvement project will evaluate the implementation of a previously described intervention (twice per week on-treatment clinical evaluations) in a feasible fashion using a previously des...
Eligibility Criteria
Inclusion
- • started outpatient radiation therapy with or without concurrent systemic therapy at Duke Cancer Center
Exclusion
- undergoing total body radiation therapy for hematopoetic stem cell transplantation
- undergoing therapy as inpatient
- treating physician who opted out of randomization
- completed radiation therapy prior to algorithm execution
Key Trial Info
Start Date :
September 7 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2019
Estimated Enrollment :
311 Patients enrolled
Trial Details
Trial ID
NCT04277650
Start Date
September 7 2018
End Date
June 30 2019
Last Update
May 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke Cancer Center
Durham, North Carolina, United States, 27710